Page 84 - Read Online

Malentacchi et al. J Cancer Metastasis Treat 2020;6:34 I http://dx.doi.org/10.20517/2394-4722.2020.34 Page 17 of 18

invasion. J Cancer Res Clin Oncol 2012;38:671-4.
70. Zhao S, Yao D, Chen J, Ding N. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical
cancer. Genet Test Mol Biomarkers 2013;17:631-6.
71. Chen J, Yao D, Li Y, Chen H, He C, et al. Serum microRNA expression levels can predict lymph node metastasis in patients with early-
stage cervical squamous cell carcinoma. Int J Mol Med 2013;32:557-67.
72. Zhao YN, Chen G, Hong SJ. Circulating MicroRNAs in gynecological malignancies: from detection to prediction. Exp Hematol Oncol
2014;3:14.
73. Wang L, Chen YJ, Xu K, Xu H, Shen XZ, et al. Circulating microRNAs as a fingerprint for endometrial endometrioid adenocarcinoma.
PLoSOne 2014;9:e110767.
74. La Ferlita A, Battaglia R, Andronico F, Caruso S, Cianci A, et al. Non-coding RNAs in endometrial physiopathology. Int J Mol Sci
2018;19:2120.
75. Gao Y, Dai M, Liu H, He W, Lin S, et al. Diagnostic value of circulating miR-21: an update meta-analysis in various cancers and
validation in endometrial cancer. Oncotarget 2016;7:68894-908.
76. Benati M, Montagnana M, Danese E, Paviati E, Giudici S, et al. Evaluation of mir-203 expression levels and DNA promoter methylation
status in serum of patients with endometrial cancer. Clin Lab 2017;63:1675-81.
77. Tessitore L, Vizio B, Pesola D, Cecchini F, Mussa A, et al. Adipocyte expression and circulating levels of leptin increase in both
gynaecological and breast cancer patients. Int J Oncol 2004;24:1529-35.
78. Qu W, Gao Q, Chen H, Tang Z, Zhu X, et al. HE4-test of urine and body fluids for diagnosis of gynecologic cancer. Expert Rev Mol
Diagn 2017;17:239-44.
79. Liang J, Yin G, Chen M, Wu A. Detection of hTERT mRNA in peripheral blood and its implication for diagnosis of early stage
postoperative endometrial cancer micrometastasis. Panminerva Med 2016;58:206-10.
80. Nazarenko I. Extracellular vesicles: recent developments in technology and perspectives for cancer liquid biopsy. Recent Results Cancer
Res 2020;215:319-44.
81. Mariscal J, Fernandez-Puente P, Calamia V, Abalo A, Santacana M, et al. Proteomic characterization of epithelial-like extracellular
vesicles in advanced endometrial cancer. J Proteome Res 2019;18:1043-53.
82. Fitts CA, Ji N, Li Y, Tan C. Exploiting exosomes in cancer liquid biopsies and drug delivery. Adv Healthcare Mater 2019;8:1801268.
83. LimW, Kim HS. Exosomes as therapeutic vehicles for cancer. Tissue Eng Regen Med 2019;16:213-23.
84. Xu H, Gong Z, Shen Y, Fang Y, Zhong S. CircularRNA expression in extracellular vesicles isolated from serum of patients with
endometrial cancer. Epigenomics 2018;10:187-97.
85. In’tVeld SGJG, Wurdinger T. Tumor-educated platelets. Blood 2019;133:2359-64.
86. Zavesky L, Jandakova E, Turyna R, Duskova D, Langmeierova L, et al. Cell-free urinary microRNAs expression in small-scale
experiments. Methods Mol Biol 2017;1580:99-106.
87. Larsen LK, Lind GE, Guldberg P, Dahl C. DNA-methylation-based detection of urological cancer in urine: overview of biomarkers and
considerations on biomarker design, source of DNA, and detection technologies. Int J Mol Sci 2019;20:2657.
88. Ye F, Tang QL, Ma F, Cai L, Chen M, et al. Analysis of the circular RNA transcriptome in the grade 3 endometrial cancer. Cancer Manag
Res 2019;11:6215-27.
89. Binesh F, Akhavan A, Behniafard N, Zabihi S, Hosseinizadeh E. Prognostic value of peritoneal washing cytology in gynecologic
malignancies: a controversial issue. Asian Pac J Cancer Prev 2014;15:9405-10.
90. Lv S, Wang R, Wang Q, Han L, Tuo X, et al. A novel solution configuration on liquid-based endometrial cytology. PLoS One
2018;13:e0190851.
91. Kinde I, Bettegowda C, Wang Y, Wu J, Agrawal N, et al. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial
cancers. Sci Transl Med 2013;5:167ra4.
92. Zhang H, Wen J, Xu PL, Chen R, Yang X, et al. Role of liquid-based cytology and cell block in the diagnosis of endometrial lesions. Chin
Med J (Engl) 2016;129:1459-63.
93. Norimatsu Y, Kouda H, Kobayashi TK, Shimizu K, Yanoh K, et al. Utility of liquid-based cytology in endometrial pathology: diagnosis
of endometrial carcinoma. Cytopathology 2009;20:395-402.
94. Buccoliero AM, Gheri CF, Castiglione F, Garbini F, Barbetti A, et al. Liquid-based endometrial cytology: cyto-histological correlation in
a population of 917 women. Cytopathology 2007;18:241-9.
95. Yap J, Salamonsen LA, Jobling T, Nicholls PK, Dimitriadis E. Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells
in women with endometrial carcinoma. ReprodBiolEndocrinol2010;8:63.
96. Maritschnegg E, Wang Y, Pecha N, Horvat R, Van Nieuwenhuysen E, et al. Lavage of the uterine cavity for molecular detection of
Mullerian duct carcinomas: a proof-of-concept study. J Clin Oncol 2015;33:4293-301.
97. Martignetti JA, Pandya D, Nagarsheth N, Chen Y, Camacho O, et al. Case report: molecular detection of endometrial precancer using a
targeted gynecologic cancer liquid biopsy. Cold Spring HarbMol Case Stud 2018;4:a003269.
98. Nair N, Camacho-Vanegas O, Rykunov D, Dashkoff M, Camacho SC, et al. Genomic analysis of uterine lavage fluid detects early
endometrial cancers and reveals a prevalent landscape of driver mutations in women without histopathologic evidence of cancer: a
prospective cross-sectional study. PLoS Med 2016;13:e1002206.
99. Roman-Canal B, Moiola CP, Gatius S, Bonnin S, Ruiz-Miró M, et al. EV-associated miRNAs from peritoneal lavage are a source of
biomarkers in endometrial cancer. Cancers 2019;11:839.
100. Galamb O, Barták BK, Kalmár A, Nagy ZB, Szigeti KA, et al. Diagnostic and prognostic potential of tissue and circulating long non-